Form 4: Sotera Health Director Receives Equity Grant

Director David E. Wheadon was granted 14,970 restricted stock units as part of the Sotera Health Company 2020 Omnibus Incentive Plan.

Summary

• Director David E. Wheadon received a grant of 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock upon vesting.
• The RSUs vest in full on the earlier of the first anniversary of the grant or the date immediately prior to the next annual shareholders meeting.
• Following this transaction, the director holds a total of 89,882 shares of common stock, including the new RSUs.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Standard retention mechanism for non-employee directors.

Negatives

• None identified; this is a routine compensatory disclosure.

Risks

• Vesting is subject to the director's continued service with the company.

Future Outlook

The RSUs are expected to vest within one year, contingent upon continued service as a non-employee director.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The grant structure follows standard industry practices for public company director compensation.
• Vesting schedules tied to annual meetings are common among mid-cap healthcare firms.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders; represents standard director compensation.

Next Steps

• Vesting of RSUs on the earlier of May 22, 2027, or the day before the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Director Compensation, Restricted Stock Units, Insider Ownership